Avanos Medical, Inc. (NYSE: AVNS) reported Q3 EPS of $0.25, $0.05 worse than the analyst estimate of $0.30. Revenue for the quarter came in at $184 million versus the consensus estimate of $185.34 million.

GUIDANCE:

Avanos Medical, Inc. sees FY2021 EPS of $1.10-$1.20, versus the consensus of $1.14.

For earnings history and earnings-related data on Avanos Medical, Inc. (AVNS) click here.